Lisa Scholz, PharmD., Sentry’s Head of Industry Relations, has published a white paper as part of the Texas Healthcare Trustees’  Governance Thought Leadership Series. The paper, “340B Program Transparency – is it ‘Trans-fair-ency’?” discusses the political, economic, social and technological factors that play into 340B program compliance and optimization, and the role that transparency plays.

Lisa has been an expert on the 340B program throughout her career, having previously served as both the vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as the chief operating officer and senior vice president at 340B Health.